3D Models | Cyprotex

Archive for the ‘3D Models’ Category

Confocal HCS image of 3D Cardiac Microtissues

Improved Detection of Cardiovascular Structural Risks using 3D Microtissues

There are three primary pathways by which drug-induced cardiovascular toxicities can manifest: Functional toxicity – electrophysiological impairments […]

New Review Published on Advanced 3D Cell-Based Models

Early prediction of drug-induced toxicity is critical to prevent liabilities being detected at a late stage when […]

Detecting Drug Cholestatic Potential using 3D Microtissues and High Content Screening

Certain drugs impair bile acid export, which can lead to intrahepatic accumulation and cause drug-induced cholestasis. Bile […]

Spontaneously Beating 3D Human Cardiac Microtissues for the Prediction of Structural Cardiotoxicity

Cardiotoxic response is the leading cause of attrition in drug development. Much emphasis has been duly placed […]

Comparison between Ultra-Low Attachment Plate and Hanging Drop Models for the Formation and Analysis of 3D Microtissues

Three-dimensional (3D) microtissues present an alternative in vitro system for ADME and Toxicology screening. The prevailing method […]

Legal Privacy Site map Careers

This website is intended to assist industry participants, customers and employees to understand Cyprotex's global operations and ambitions.

Archive for the ‘3D Models’ Category

Improved Detection of Cardiovascular Structural Risks using 3D Microtissues

New Review Published on Advanced 3D Cell-Based Models

Detecting Drug Cholestatic Potential using 3D Microtissues and High Content Screening

Spontaneously Beating 3D Human Cardiac Microtissues for the Prediction of Structural Cardiotoxicity

Comparison between Ultra-Low Attachment Plate and Hanging Drop Models for the Formation and Analysis of 3D Microtissues

United Kingdom (HQ)

United States